Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-UK plant that makes Astra vaccines partially evacuated over suspect package

Wed, 27th Jan 2021 13:15

(Adds company statement)

LONDON, Jan 27 (Reuters) - A plant in Wales that produces
anti-COVID vaccines for AstraZeneca has been partially evacuated
after a suspicious package was received, the company that
operates it said on Wednesday.

"Wockhardt UK in Wrexham this morning received a suspicious
package to site. All relevant authorities were immediately
notified and engaged," the company said, referring to its
facility in Wales.

"Upon expert advice we have partially evacuated the site
pending a full investigation. The safety of our employees and
business continuity remain of paramount importance."

Earlier, the BBC reported that a police bomb disposal unit
has been sent to the plant.
(Reporting by Alistair Smout, writing by Estelle Shirbon;
editing by Guy Faulconbridge)

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.